• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Catalog Number HT076080
Device Problem Contamination (1120)
Patient Problem Unspecified Infection (1930)
Event Date 11/17/2020
Event Type  Injury  
Manufacturer Narrative
Analysis-report from third party was received and will be further investigated.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
It was reported to gore that patient underwent endovascular treatment for a right-left crossed femoro-femoral bypass with a gore® propaten® vascular graft - thin-walled removable ringed.It was stated that the prosthesis was implanted on (b)(6) 2020 in order to treat an acute ischemia of the left lower limb following the treatment of a type a aortic dissection by open surgery.It was reported that on (b)(6) 2020, after about 2 months, the distal part of the prosthesis was explanted due to a rupture of the distal anastomosis (case (b)(4)).It was stated that 6 days later, the rest of the prosthesis was explanted due to the infection.
 
Manufacturer Narrative
H6 evaluation codes investigation findings 213 refers to the phr-review: a review of the manufacturing records indicated the released portion of the lot met all pre-release specifications.Analysis-report from third party was received and will be further investigated.
 
Manufacturer Narrative
Explant investigation: the device was returned to geprovas for investigation.Submitted in formalin was one gore® propaten® vascular graft fragment.The scope and results of the investigation were summarized, and a report was submitted to w.L.Gore & associates.An explant scientist at w.L.Gore & associates reviewed the report and performed in person on-site evaluation of the specimen.Explant scientist observations: the graft fragment was reported to measure 120 mm in length with both ends transected.The ablumen was encased in light tan/tan tissue with multifocal deposits yellow (presumed adipose) tissue.Blue alignment marks were faintly visible on inspection.The lumen of extremity a was occupied with gelatinous brown tissue.Extremity b was ligated with multifilament blue-green suture in a continuous running pattern.The graft fragment was not patent.Reason: based on the explant scientist¿s review of the geprovas report, no additional analysis is requested.The reported reason for removal was infection with no accusation of infection being device related from the physician.The origin of infection cannot be determined with the information provided nor via the analyses available.
 
Manufacturer Narrative
Product history review: a review of the sterilization records indicated the lot met all pre-release specifications.
 
Manufacturer Narrative
Added to section c1: suspect products: name: cbas® heparin surface.Manufacturer/compounder: w.L.Gore & associates, inc.Lot number: 6670923pp002.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11313502
MDR Text Key231369965
Report Number2017233-2021-01663
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeFR
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/11/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/06/2024
Device Catalogue NumberHT076080
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/07/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
Patient SexMale
-
-